Tuberculosis (TB) is the leading infectious cause of morbidity and mortality globally. Despite
available tools for preventing, finding, and treating TB, many people with TB remain …

New drugs and shorter treatments for drug-resistant tuberculosis (DR-TB) have become
available in recent years and active pharmacovigilance (PV) is recommended by the World …

Vietnam has been using a levofloxacin-based shorter treatment regimen (STR) for rifampicin
resistant/multidrug-resistant tuberculosis (RR/MDR-TB) patients since 2016 on a pilot basis. …

The emergence in 2006 of extensively drug-resistant strains of tuberculosis, especially in
countries with a high prevalence of human immunodeficiency virus, are serious threats to …

The emergence in 2006 of extensively drug-resistant strains of tuberculosis, especially in
countries with a high prevalence of human immunodeficiency virus, is a serious threat to global …

The World Health Organization (WHO) has produced this WHO operational handbook on
tuberculosis to provide practical advice to complement the latest WHO consolidated guidelines …

Operational handbook on tuberculosis. Module 4: Treatment of drug-resistant tuberculosis
treatment, is a derivative product arising from the guideline on the same topic. This …

(DR-TB) are urgently needed. In 2013, only 45% of the estimated 300 000 cases of patients
with multidrug-resistant TB (MDR-TB; ie resistance to at least rifampicin and isoniazid) were …

… Le TN Anh, Ajay MV Kumar, Gomathi Ramaswamy, Thurain Htun, Thuy Thanh Hoang Thi,
Giang Hoai Nguyen, Mamel Quelapio, Agnes Gebhard, Hoa Binh Nguyen and Nhung Viet …

Background The WHO has issued a call to action urging countries to accelerate the rollout
of new WHO-recommended shorter all-oral treatment regimens for drug-resistant TB (DR-TB), …